Stock Watch: Novo Nordisk, Lilly Usher In GLP-1 Halo Effect
Obesity’s Rising Tide Lifts Other Therapy Categories
Two pharmaceutical companies reporting bumper sales in the hot areas of diabetes and obesity may have helped a thaw in sector sentiment.
Two pharmaceutical companies reporting bumper sales in the hot areas of diabetes and obesity may have helped a thaw in sector sentiment.